25
Participants
Start Date
May 4, 2021
Primary Completion Date
December 12, 2022
Study Completion Date
December 12, 2022
DHP107(Oral paclitaxel)
DHP107 200 mg/m\^2 orally twice daily on Day 1, 8, and 15 in every 28 days (On food effect study day, DHP107 200 mg/m\^2 orally once daily on Day 1, 8 of Cycle 1 with fasted or fed condition according to the assigned sequence)
University of Semmelweis, 1st Internal Medicine Clinic, Department of Clinical Pharmacology, Budapest
National Institute of Oncology, Budapest
Clinexpert Ltd Phase I. Studycenter, Gyöngyös
University of Debrecen-Clinical Center, Internal Medicine Clinic, Department of Clinical Pharmacology, Debrecen
University of Szeged, Dermatology and Allergology Clinic, Phase I. Investigational site, Szeged
Lead Sponsor
Daehwa Pharmaceutical Co., Ltd.
INDUSTRY